The impact of co-morbidity on life expectancy among men with localized prostate cancer

Journal of Urology

Volumn 156, Issue 1, 1996, Pages 127-132

  Albertsen, Peter C ^b   Fryback, Dennis G ^b   Storer, Barry E ^b   Kolon, Thomas F ^b   Fine, Judith ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b NONE

Author keywords

comorbidity; life expectancy; prostatic neoplasms

Indexed keywords

AGED; ARTICLE; BRACHYTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOSURGERY; HORMONAL THERAPY; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

EID: 0029934494     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65964-0     Document Type: Article

References (10)

1. Albertsen, P.: A 72-year-old man with localized prostate cancer. J.A.M.A., 274: 69, 1995.
2. Brendler, C. B. and Walsh, P. C.: The role of radical prostatectomy in the treatment of prostate cancer. CA, 42: 212, 1992.
3. Bagshaw, M. A., Cox, R. S. and Hancock, S. L.: Control of prostate cancer with radiation therapy: long-term results. J. Urol., part 2, 152: 1781, 1994.
4. Albertsen, P. C., Fryback, D. G., Storer, B. E., Kolon, T. F. and Fine, J.: Long-term survival among men with conservatively treated localized prostate cancer. J.A.M.A., 274: 626, 1995.
5. Greenfield, S., Apolone, G., McNeil, B. J. and Cleary, P. D.: The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med. Care., 31: 141, 1993.
6. Charlson, M. E., Pompie, P., Ales, K. L. and MacKenzie, C. R.: A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J. Chron. Dis., 40: 373, 1987.
7. Kaplan, M. H. and Feinstein, A. R.: The importance of classifying initial co-morbidity in evaluating the outcomes of diabetes mellitus. J. Chron. Dis., 27: 387, 1974.
8. Catalona, W. J. and Whitmore, W. F., Jr.: New staging systems for prostate cancer. J. Urol., 142: 1302, 1989.
9. Kalbfleisch, J. D. and Prentice, R. L.: The Statistical Analysis of Failure Time Data. New York: John Wiley & Sons, 1980.
10. Wasson, J. H., Cushman, C. C., Bruskewitz, R. C., Littenberg, B., Mulley, A. G., Jr. and Wennberg, J. E.: A structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research Team. Arch. Fam. Med., 2: 487, 1993.